Biotech Bay
Filter News
Found 85,055 articles
-
OncoLogics, Inc. Appoints Stephen T. Isaacs as President and Chief Executive Officer
3/7/2007
-
Interview Tips
3/7/2007
-
Coming to Terms with the Past
3/7/2007
-
Eksigent Technologies Moves NanoLC Distribution Into France with Serlabo Technologies
3/7/2007
-
Avicena Group, Inc. Receives Additional U.S. Patent Claim Covering Use of Creatine or Creatine Compounds for Skin Preservation
3/7/2007
-
XOMA (US) LLC Announces Automatic Conversion of All Remaining Outstanding Convertible Notes
3/7/2007
-
Tercica, Inc. to Hold Conference Call Discussing Litigation Settlement with Insmed Incorporated on Wednesday, March 7
3/7/2007
-
Litigation Settlement Reached Between Tercica, Inc., Genentech, Inc. and Insmed Incorporated
3/7/2007
-
FDA Accepts for Review New Roche Diagnostics Blood Screening Test
3/7/2007
-
Velos, Inc. Releases Version 7 of Market Leading Clinical Trial Software
3/7/2007
-
A.P. Pharma, Inc. Reports Results for the Fourth Quarter and Full Year 2006; Reports on Progress of APF530 Program
3/7/2007
-
Conformia Expands FDA Expertise With Appointment of Former Capgemini Life Sciences Division Executive
3/7/2007
-
Cell Genesys, Inc. to Webcast Presentation at the SG Cowen & Co. Health Care Conference
3/7/2007
-
KOSAN Biosciences, Inc. to Present at the Cowen and Company 27th Annual Health Care Conference
3/7/2007
-
Affymax, Inc. to Present at Cowen and Company Health Care Conference
3/7/2007
-
BioMarin Pharmaceutical Inc. to Present at the Cowen and Company 27th Annual Health Care Conference
3/7/2007
-
Sunesis Pharmaceuticals, Inc. to Present at the Cowen and Company 27th Annual Health Care Conference
3/7/2007
-
Sangamo BioSciences, Inc. to Present at the Cowen and Company 27th Annual Health Care Conference
3/7/2007
-
InterMune, Inc. (Jobs) Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
3/6/2007
-
TransOral Pharmaceuticals, Inc. Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
3/6/2007